(Q28548702)

English

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study (English)

0 references

infectious disease

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

ChEBI release 2020-05-28

13

0 references

Koert Ritmeijer

2

0 references

Raffaella Ravinetto

7

0 references

Marleen Boelaert

3

0 references

Robert Colebunders

11

object named as

Robert Colebunders

0 references

15

object named as

Asrat Hailu

0 references

Johan van Griensven

16

object named as

Johan van Griensven

0 references

author name string

Ermias Diro

1

0 references

Fabiana Alves

4

0 references

Rezika Mohammed

5

0 references

Charles Abongomera

6

0 references

Maaike De Crop

8

0 references

Helina Fikre

9

0 references

Cherinet Adera

10

0 references

Harry van Loen

12

0 references

Lutgarde Lynen

14

0 references

language of work or name

0 references

publication date

2015

0 references

PLoS Neglected Tropical Diseases

0 references

9

0 references

10

0 references

e0004087

0 references

copyright license

Creative Commons Attribution 4.0 International

2 October 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

19 March 2017

Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

19 March 2017

Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Pentamidine dosage: a base/salt confusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

HIV and the transmission of Leishmania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Visceral leishmaniasis in patients infected with the human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

29 September 2017

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

3 June 2018

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

3 June 2018

Visceral leishmaniasis in an AIDS patient on successful antiretroviral therapy: failure of parasite eradication despite increase in CD4+ T-cell count but low CD8+ T-cell count

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004087

21 January 2018

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004087

21 January 2018

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004087

21 January 2018

Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004087

21 January 2018

Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0004087

21 January 2018

Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

27 November 2018

Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4591988

27 November 2018

Identifiers

10.1371/JOURNAL.PNTD.0004087

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28548702&oldid=1854939468"